摘要
目的：比较新型糖化血红蛋白测定仪拜安时与D10糖化血红蛋白测定仪的临床实用性.方法：选取郑州大学人民医院2013年1月至6月住院糖尿病患者及非糖尿病志愿者共99例（HbAlc：5％～13％）,按照HbAlc分成A、B、C共3组,同一观察对象的同一标本分别用拜安时及D10测定HbAlc并进行比较.标本来源分别为末梢血、静脉血.结果：末梢血结果：拜安时与D1O结果相近,变异系数＜5％,差异无统计学意义（P＞0.05）;静脉血结果：拜安时与D10结果相比差值较大,变异系数较高,差异有统计学意义（P＜0.05）.而随着糖化值逐渐增高,无论是取静脉血或末梢血,变异百分比均呈增大趋势.结论：以D10测定结果为对照,拜安时取末梢血测定HbAlc结果比取静脉血测定HbAlc准确可靠.
Objective： To compare the clinical practicability between glycosylated hemoglobin ana- lyzer A1CNow ＋ and D10. Methods： 99 cases with HbAlc in 5% -13% including inpatients and healthy volunteers were selected from January 2013 to June 2013 in the People＇ s Hospital of Zhengzhou University. They were divided into 3 groups according to the percentage of HbAle. The specimens were detected by A1CNow ＋ and D10 respectively. The specimens were from peripheral blood and venous blood. Results： The results of peripheral blood detected by A1CNow ＋ and D10 were similar. The variation coefficient was less than 5% ,the difference was not statistically significant （P 〉0.05）. The results of venous blood detected by A1CNow ＋ and D10 were different,the variation coefficient was 5.10% - 10.58% , the difference was statistically significant （P 〈0.05 ）. As glycated hemoglobin values increased gradually,the variation percentage showed an increasing trend no matter in peripheral blood or venous blood. Conclusion ： With the results of D10 as reference,the results of peripheral blood detected by A1CNow ＋ are more accurate and reliable than that of venous blood.
出处
《河南医学研究》
CAS
2014年第1期16-18,共3页
Henan Medical Research
